日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pre-COVID-19 ex vivo cross-reactive IFN-γ cellular response to SARS-CoV-2 spike overlapping peptides is more prevalent among Kenyan compared to Swedish adults

与瑞典成年人相比,肯尼亚成年人中针对SARS-CoV-2刺突蛋白重叠肽的体外交叉反应性IFN-γ细胞应答在COVID-19疫情前更为普遍。

Wanjiku, Perpetual; Orindi, Benedict; Mwacharo, Jedidah; Chemweno, James; Karanja, Henry Kibe; Kronsteiner, Barbara; Kai, Oscar; Wright, Daniel; Ochola-Oyier, Lynette Isabella; Sundling, Christopher; Dunachie, Susanna; Warimwe, George M; Färnert, Anna; Bejon, Philip; Ndungu, Francis M; Nduati, Eunice W

Low-Dose Yellow Fever Vaccine in Adults in Africa

非洲成年人低剂量黄热病疫苗

Kimathi, Derick; Juan-Giner, Aitana; Bob, Ndeye S; Orindi, Benedict; Namulwana, Maria L; Diatta, Antoine; Cheruiyot, Stanley; Fall, Gamou; Dia, Moussa; Hamaluba, Mainga M; Nyehangane, Dan; Karanja, Henry K; Gitonga, John N; Mugo, Daisy; Omuoyo, Donwilliams O; Hussein, Mwatasa; Oloo, Elizaphan; Kamau, Naomi; Wafula, Jackline; Bendera, Josephine; Silvester, Namanya; Mwavita, James; Joshua, Musiimenta; Mwendwa, Jane; Agababyona, Collins; Ngetsa, Caroline; Aisha, Nalusaji; Moki, Felix; Buluku, Titus; Munene, Marianne; Mwanga-Amumpaire, Juliet; Lutwama, Julius; Kayiwa, John; Kamaara, Eunice; Barrett, Alan D; Kaleebu, Pontiano; Bejon, Philip; Sall, Amadou A; Grais, Rebecca F; Warimwe, George M

Age differences in immunity to human seasonal coronaviruses and the immunogenicity of ChAdOx1 nCoV-19 (AZD1222).

人类季节性冠状病毒免疫力的年龄差异以及 ChAdOx1 nCoV-19 (AZD1222) 的免疫原性

Belij-Rammerstorfer Sandra, Sheehan Emma, Li Grace, Bibi Sagida, Wright Daniel, Voysey Merryn, Bissett Cameron, Barman Ninisha, Camara Susana, Yong Audrey Au, Costa Clemens Sue Ann, Harris Mae, Flaxman Amy, Barrett Jordan, Hussain Khiyam, Lipunga Gareth, Shaw Robert H, Smith Holly, Cheruiyot Stanley, Gitonga John N, Mugo Daisy, Karanja Henry K, Warimwe George M, Hamaluba Mainga M, Weckx Lily Y, Pollard Andrew J, Lambe Teresa

Assessing the Impact of SARS-CoV-2 Spike Mutations on Antibody Binding: A Comparative Assessment of the Wuhan and JN.1 Variants' Full-Length Spikes in a Multiplex Luminex Assay

评估SARS-CoV-2刺突蛋白突变对抗体结合的影响:基于多重Luminex检测的武汉株和JN.1株全长刺突蛋白的比较分析

Waweru, Gerald; Nyakundi, Ruth; Kutima, Bernadette; Owuor, Sharon; Konyino, Gloria; Gitonga, John; Lugano, Doreen; Maina, Angela; Musyoki, Jennifer; Ochola, Lucy; Omondi, Martin; Kariuki, Christopher K; Ogongo, Paul; Mwachari, Christina; Shee, Faiz; Agoti, Charles; Sande, Charles; Uyoga, Sophie; Kagucia, Eunice; Agweyu, Ambrose; Bejon, Philip; Scott, J Anthony G; Warimwe, George M; Ochola-Oyier, L Isabella; Nyagwange, James

Rift Valley fever seroprevalence and risk factors among human populations in Uganda's cattle corridor: a cross-sectional study

乌干达牛走廊地区人群中裂谷热血清阳性率及危险因素:一项横断面研究

Anywaine, Zacchaeus; Wright, Daniel; Warimwe, George M; Kaleebu, Pontiano; Elliott, Alison; Hansen, Christian

Severe morbidity and hospital-based mortality from Rift Valley fever disease between November 2017 and March 2020 among humans in Uganda

2017年11月至2020年3月期间,乌干达人类中裂谷热病的严重发病率和住院死亡率

Anywaine, Zacchaeus; Hansen, Christian; Warimwe, George M; Abu-Baker Mustapher, Ggayi; Nyakarahuka, Luke; Balinandi, Stephen; Ario, Alex Riolexus; Lutwama, Julius J; Elliott, Alison; Kaleebu, Pontiano

Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration

简介:肯尼亚多点血清监测(KEMIS)合作项目

Kagucia, E Wangeci; Voller, Shirine; Ziraba, Abdhalah K; Bigogo, Godfrey; Munywoki, Patrick K; Makobu, Kimani; Nokes, D James; Nyagwange, James; Orlendo, Cameline; Akech, Donald; Sigilai, Antipa; Onyango, Clayton; Juma, Bonventure; Herman-Roloff, Amy; Munyua, Peninah; Apondi, Caroline; Lidechi, Shirley; Audi, Allan; Ouma, Alice; Aol, George; Misore, Thomas; Nasimiyu, Caroline; Onyango, Dickens; Lo, Terrence; Kasera, Kadondi; Jalang'o, Rose; Kingwara, Leonard; Adetifa, Ifedayo; Etyang, Anthony O; Warimwe, George; Agweyu, Ambrose; Scott, J Anthony G

Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial

ChAdOx1疫苗在英国成人中预防裂谷热的安全性和免疫原性:一项开放标签、非随机、首次人体I期临床试验

Jenkin, Daniel; Wright, Daniel; Folegatti, Pedro M; Platt, Abigail; Poulton, Ian; Lawrie, Alison; Tran, Nguyen; Boyd, Amy; Turner, Cheryl; Gitonga, John N; Karanja, Henry K; Mugo, Daisy; Ewer, Katie J; Bowden, Thomas A; Gilbert, Sarah C; Charleston, Bryan; Kaleebu, Pontiano; Hill, Adrian V S; Warimwe, George M

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

在肯尼亚 HIV 感染者中,17D-213 黄热病疫苗分剂量接种的免疫原性和安全性 (YEFE):一项 4 期试验的随机、双盲、非劣效性子研究

Kimathi, Derick; Juan-Giner, Aitana; Orindi, Benedict; Grantz, Kyra H; Bob, Ndeye S; Cheruiyot, Stanley; Hamaluba, Mainga; Kamau, Naomi; Fall, Gamou; Dia, Moussa; Mosobo, Moses; Moki, Felix; Kiogora, Kenneth; Chirro, Oscar; Thiong'o, Alexander; Mwendwa, Jane; Guantai, Andrew; Karanja, Henry K; Gitonga, John; Mugo, Daisy; Ramko, Kelly; Faye, Ousmane; Sanders, Eduard J; Grais, Rebecca F; Bejon, Philip; Warimwe, George M

SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022

SARS-CoV-2 血清阳性率及其对人群免疫力的影响:来自肯尼亚两个健康和人口监测系统站点的证据(2022 年 2 月至 12 月)

Kagucia, E Wangeci; Ziraba, Abdhala K; Nyagwange, James; Kutima, Bernadette; Kimani, Makobu; Akech, Donald; Ng'oda, Maurine; Sigilai, Antipa; Mugo, Daisy; Karanja, Henry; Gitonga, John; Karani, Angela; Toroitich, Monica; Karia, Boniface; Otiende, Mark; Njeri, Anne; Aman, Rashid; Amoth, Patrick; Mwangangi, Mercy; Kasera, Kadondi; Ng'ang'a, Wangari; Voller, Shirine; Ochola-Oyier, Lynette I; Bottomley, Christian; Nyaguara, Amek; Munywoki, Patrick K; Bigogo, Godfrey; Maitha, Eric; Uyoga, Sophie; Gallagher, Katherine E; Etyang, Anthony O; Barasa, Edwine; Mwangangi, Joseph; Bejon, Philip; Adetifa, Ifedayo M O; Warimwe, George M; Scott, J Anthony G; Agweyu, Ambrose